'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat
Sandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply.
Sandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply. This story matters for Finance & Markets readers tracking expo. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. ExpoNews curates and briefs the finance & markets stories that matter. Our editorial policy →